News
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
11h
News-Medical.Net on MSNTirzepatide outperforms semaglutide for weight loss in people without diabetesA head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
TWO blockbuster weight loss jabs have been tested against each other for the first time in a head-to-head trial. There was a ...
Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...
GLP-1 injections such as tirzepatide and semaglutide come with a catch. Here’s the natural alternative doctors recommend.
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are ...
Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%.
New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results